Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio

Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications

Eni and Dompe farmaceutici join forces for health research

Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients

Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib

The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Veramed acquires Clinical Trial Data Services

Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.

Emmes acquires VaxTRIALS

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth

Cambrex completes US$38 million capacity expansion in High Point, North Carolina

Solvay celebrates Medicine Nobel Prize winner Katalin Karikó

Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance

SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology